Skip to main content

Eric W. Wang, MD

  • Executive Vice Chair, Department of Otolaryngology-Head and Neck Surgery
  • Professor, Departments of Otolaryngology-Head and Neck Surgery, Neurological Surgery, and Ophthalmology
  • Director of Education, UPMC Center for Cranial Base Surgery
  • Chief, Division of Rhinology, University of Pittsburgh Medical Center

Dr. Wang specializes in rhinology and skull base surgery.  His areas of focus include the management of chronic rhinosinusitis including revision endoscopic sinus surgery, nasal airway surgery, endoscopic orbital surgery, repair of CSF leaks, and management of sinonasal and anterior cranial fossa tumors.

Dr. Wang is a diplomate of the American Board of Otolaryngology and a Fellow of the American College of Surgeons. He is also a member of the American Academy of Otolaryngology – Head & Neck Surgery, the Triological Society, the American Rhinologic Society, and the North American Skull Base Society.  Dr. Wang has published more than 200 articles in the peer-reviewed literature, presented multiple national podium lectures, and participated as course faculty or course co-director of more than 50 endoscopic courses. He is an Associate Editor for the American Journal of Rhinology and Allergy and serves on the editorial board of the International Forum of Allergy and Rhinology and The Laryngoscope.


    Education & Training

  • Medical University of South Carolina, Fellowship in Rhinology and Endoscopic Skull Base Surgery
  • Barnes-Jewish Hospital and Washington University School of Medicine, Two-Year NIH Research Fellowship, Chronic Infections of the Head and Neck
  • Barnes-Jewish Hospital and Washington University School of Medicine, Otolaryngology Internship & Residency
  • Baylor College of Medicine, MD
  • Rice University, BS, Biochemistry
Best Doctors in America, 2013-Present
Best Doctors in Pittsburgh, Pittsburgh Magazine, 2014-Present
Research Interests

As a member of the UPMC Center for Cranial Base Surgery, Dr. Wang has designed and implemented multiple prospective controlled trials on the outcomes and consequences of skull base surgery. In addition to outcomes research, he also is active in translational research. Through exome sequencing and mutation analysis, Dr. Wang aims to determine molecular targets for the adjuvant treatment of clival chordoma, a locally aggressive malignancy of the skull base and an area of clinical expertise at the UPMC. He is the site lead investigator for a national multi-institutional prospective trial on sinonasal malignancies. His second primary area of investigation is the microbiome of the paranasal sinus and its implications in chronic inflammatory rhinosinusitis. Through collaborations within rhinology and pulmonology, the role of viruses and bacteria in maintaining inflammatory homeostasis and reflecting pro-inflammatory disease states within the sinonasal mucosa is under active investigation.